Clinical science supporting women's well-being after 40
Decoding the biological mechanisms of the menopausal transition through peer-reviewed clinical research (EMAS, BJOG, Nature, BMS, PubMed).
Reviewed by the Nuellia Scientific Advisory Board
Medical ontology ICD-10 : N95.1 (Menopausal & Perimenopausal States)
Updated : October 2026
Epidemiological evidence
Executive summary & epidemiological benchmarks
Public health metrics and demographic evidence sourced from leading European and international clinical cohorts.
100 million
Women aged 45 and over in Europe
Source : Eurostat / WHO Europe
51 to 52 years
Average age of menopause onset in Europe
Source : European Menopause and Andropause Society (EMAS)
87%
Report at least one bothersome symptom
Source : EMAS epidemiological consensus
4 to 7 years
Average duration of the perimenopausal transition
Source : British Menopause Society (BMS) / EMAS
Core foundations
Three core scientific pillars
From mitochondrial photonics to circadian chronobiology : grounded solutions addressing specific physiological shifts.
Skin Biology & Photonics
Collagen Reactivation through Photobiomodulation
Mitochondrial stimulation at 630 nm & 850 nm to offset 30% dermal depletion
During menopause, estrogen withdrawal decelerates fibroblast activity. Topical collagen creams cannot penetrate the stratum corneum due to the 500-dalton molecular rule. Red light (630 nm) and near-infrared (850 nm) bypass the surface barrier to directly stimulate mitochondrial cytochrome c oxidase, boosting cellular ATP and collagen I & III synthesis.
Validated biological mechanism
Mitochondrial photoreceptors -> cytochrome c oxidase -> cellular ATP surge -> fibroblast neocollagenesis.
Four adaptogenic mushrooms combined with natural organic vitamin C
Many women cannot or choose not to use phytoestrogens (such as soy or red clover). Nuellia relies on targeted mycotherapy instead. Reishi (Ganoderma lucidum), titrated in triterpenes and beta-glucans, moderates neuro-endocrine cortisol spikes. The formula also includes Maitake, Shiitake, Cordyceps plus organic acerola extract, supporting immune defenses and cellular vitality without hormonal activity inside pullulan capsules.
Validated biological mechanism
Triterpenes + beta-glucans -> adrenal receptor modulation -> blunted cortisol peaks -> steady stamina with zero hormonal interference.
The singular dietary supplement in the Nuellia collection
Nuellia formulation charter
Validated through 1 clinical publications.
Clinical trials registry
Summary table of peer-reviewed clinical trials
Every figure and mechanism is directly anchored in peer-reviewed biomedical literature.
Study & Authors
Journal & Year
Measured clinical outcome
Application & Protocol
Official reference
Decrease of skin collagen in postmenopausal women and its correlation with estrogen decline
Dr Mark Brincat, E. Versi, T. O'Dowd, et al.
BJOG & King's College London
British Journal of Obstetrics and Gynaecology (BJOG)
1987
-30% : Dermal collagen lost during the first 5 postmenopausal years
Documented loss of 30% of dermal collagen within the first 5 years of estrogen decline, followed by a continuous reduction of approximately 2.1% per year.
Underpins targeted fibroblast reactivation through photobiomodulation to trigger neocollagenesis without relying on synthetic hormonal therapies.
A controlled trial to determine the efficacy of red and near-infrared light treatment on intradermal collagen density and skin roughness
Alexander Wunsch, Karsten Matuschka
Photomedicine and Laser Surgery
Photomedicine and Laser Surgery
2014
+31% : Average gain in intradermal collagen density
Highly significant increase in intradermal collagen density (+31%) evaluated through high-frequency 22 MHz ultrasound, along with marked wrinkle reduction and improved elasticity.
Scientific benchmark calibrating the exact irradiance and dual wavelengths of the Nuellia 4D Phototherapy Mask (630 nm red and 850 nm near-infrared).
Sleep disorders, circadian disruptions, and HPA axis dysfunction in perimenopausal women
F. C. Baker, L. Lampio, T. Saaresranta, P. Polo-Kantola
British Menopause Society (BMS)
Maturitas & British Menopause Society (BMS)
2018
61% : Women 45+ affected by regular nocturnal awakenings
61% of perimenopausal women experience maintenance insomnia with recurrent awakenings between 2 AM and 4 AM, triggered by nocturnal adrenergic spikes and HPA axis hyperarousal.
Engineers the EyZa thermal eye massager to trigger parasympathetic tone and relieve trigeminal nerve tension prior to sleep.
Thermoregulatory cooling, distal vasodilation, and rapid sleep onset
Kurt Kraeuchi, Christian Cajochen, Esther Werth, Anna Wirz-Justice
Nature / Centre for Chronobiology (Basel)
Nature
1999
40-42°C : Optimal thermal window for neuromuscular decompression
Gentle calibrated heat (40 to 42 degrees Celsius) applied to reflex zones promotes peripheral vasodilation and core body cooling, halving sleep onset latency.
Precise 42 degrees Celsius thermostatic regulation in EyZa to induce peri-orbital relaxation and biological sleep onset cues.
Reishi triterpenes and beta-glucans exert adaptogenic balance on the HPA axis without activating estrogen receptors ER-alpha or ER-beta, ensuring non-hormonal safety for women 40+.
Formulation of Immu'Boost as Nuellia's singular dietary supplement, combining 4 adaptogenic mushrooms and organic acerola without phytoestrogenic risks.
Epidemiology of menopause and public health data across Europe
European Menopause and Andropause Society (EMAS) & OMS Europe
EMAS & Eurostat
Maturitas & Consensus Europeen EMAS
2023
100M : Women aged 45 and over in Europe
Across Europe, over 100 million women are over 45. The average age of menopause is 51 to 52, and nearly 87% report at least one physical, vasomotor, or sleep-related symptom requiring supportive care.
Establishes Nuellia's target framework : delivering clean mechanical, photonic, and nutritional support for millions of women across Europe.
British Journal of Obstetrics and Gynaecology (BJOG) (1987)
Decrease of skin collagen in postmenopausal women and its correlation with estrogen decline
Dr Mark Brincat, E. Versi, T. O'Dowd, et al.
-30% : Dermal collagen lost during the first 5 postmenopausal years
Documented loss of 30% of dermal collagen within the first 5 years of estrogen decline, followed by a continuous reduction of approximately 2.1% per year.
A controlled trial to determine the efficacy of red and near-infrared light treatment on intradermal collagen density and skin roughness
Alexander Wunsch, Karsten Matuschka
+31% : Average gain in intradermal collagen density
Highly significant increase in intradermal collagen density (+31%) evaluated through high-frequency 22 MHz ultrasound, along with marked wrinkle reduction and improved elasticity.
Maturitas & British Menopause Society (BMS) (2018)
Sleep disorders, circadian disruptions, and HPA axis dysfunction in perimenopausal women
F. C. Baker, L. Lampio, T. Saaresranta, P. Polo-Kantola
61% : Women 45+ affected by regular nocturnal awakenings
61% of perimenopausal women experience maintenance insomnia with recurrent awakenings between 2 AM and 4 AM, triggered by nocturnal adrenergic spikes and HPA axis hyperarousal.
Thermoregulatory cooling, distal vasodilation, and rapid sleep onset
Kurt Kraeuchi, Christian Cajochen, Esther Werth, Anna Wirz-Justice
40-42°C : Optimal thermal window for neuromuscular decompression
Gentle calibrated heat (40 to 42 degrees Celsius) applied to reflex zones promotes peripheral vasodilation and core body cooling, halving sleep onset latency.
Reishi triterpenes and beta-glucans exert adaptogenic balance on the HPA axis without activating estrogen receptors ER-alpha or ER-beta, ensuring non-hormonal safety for women 40+.
Epidemiology of menopause and public health data across Europe
European Menopause and Andropause Society (EMAS) & OMS Europe
100M : Women aged 45 and over in Europe
Across Europe, over 100 million women are over 45. The average age of menopause is 51 to 52, and nearly 87% report at least one physical, vasomotor, or sleep-related symptom requiring supportive care.
Cite this research dossier (Press & Academic resource)
All data on this page is openly accessible under Creative Commons CC BY-ND 4.0. Journalists and health writers may freely cite these findings with source attribution.
Nuellia Scientific Advisory Board. (2026). Clinical research dossier and benchmarks: Menopausal transition, dermal collagen depletion, and sleep chronobiology after 40. Nuellia. https://www.nuellia.com/en/science
Medical disclaimer : The clinical studies, technological analyses, and scientific benchmarks presented in this dossier are for educational and informational purposes only. Nuellia wellness accessories and natural protocols do not claim to diagnose, treat, or replace medical consultations. Always consult your healthcare professional or gynecologist regarding personal health questions during perimenopause and menopause.
Clinical Science & Evidence-Based Research | Nuellia